Richard S. Kang

929 citations
15 papers · 745 indexed · h-index 9
Topics
RNA Interference and Gene Delivery (6 papers)Immunotherapy and Immune Responses (4 papers)Cellular transport and secretion (3 papers)

In The Last Decade

Richard S. Kang

14 papers receiving 734 citations

Peers

Richard S. Kang
Comparison fields: 5 of 71
  • Molecular Biology 588
  • Cell Biology 179
  • Immunology 151
  • Oncology 87
  • Biomedical Engineering 66
Replace Anna Dart with:
Anna Dart United Kingdom
Mihue Jang South Korea
Richard G. Yau United States
Hung Do United States
Ashley M. Lakoduk United States
Ben Nichols United Kingdom
Randy Suryadinata Australia
Mandy Ludford‐Menting Australia
Kamala Kesavan United States
Zhongdong Huang United States
Richard S. Kang relative to Anna Dart United Kingdom Anna Dart's profile →
Citations per field
00.5×1.5×2.1×
Anna Dart · 1×
Citations per year

Countries citing papers authored by Richard S. Kang

Since Specialization
Citations

This map shows the geographic impact of Richard S. Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard S. Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard S. Kang more than expected).

Fields of papers citing papers by Richard S. Kang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard S. Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard S. Kang. The network helps show where Richard S. Kang may publish in the future.

Co-authorship network of co-authors of Richard S. Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Richard S. Kang. A scholar is included among the top collaborators of Richard S. Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard S. Kang. Richard S. Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 0
2 49
3 2
4 6
5 216
6 2
7 4
8 27
9 43
10 7
11 43
12 66
13 26
14 60
15 194

About Richard S. Kang

Richard S. Kang is a scholar working on Cell Biology, Molecular Biology and Immunology, having authored 15 papers that have together received 745 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Immunotherapy and Immune Responses (4 papers) and Cellular transport and secretion (3 papers). The work is most often cited by research in Cell Biology (179 citations), Molecular Biology (588 citations) and Immunology (151 citations). Richard S. Kang has collaborated with scholars based in United States, France and Israel. Frequent co-authors include Ishwar Radhakrishnan, Heike Fölsch, William Salerno, Linda Hicke, Sergei Gryaznov, Liangliang Hao, Timothy J. Merkel, Natalia Chernyak, Aleksandar F. Radovic‐Moreno and David Walker. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and The Journal of Cell Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026